Kent Imaging appoints Jeffrey Niezgoda, MD., as Chief Medical Officer, Limb Preservation
Experienced health executive and wound care expert brings proven expertise and guidance on the use of near-infrared imaging technology.
Kent Imaging is pleased to announce the appointment of Jeffrey Niezgoda, MD, FACHM, MAPWCA, CHWS as Chief Medical Officer. In his new role, Dr. Niezgoda will be responsible for providing medical and clinical leadership for Kent’s wound care, hyperbaric and vascular surgery product strategy, and clinical integration.
“I am honored to serve as Chief Medical Officer for Kent Imaging. Snapshot technology is truly revolutionary and will have an indelible impact on the practice of wound care,” says Dr. Niezgoda. He adds, “for years, clinicians relied upon physical exam and crude testing devices that at best only provided a guesstimate of tissue perfusion. Near-infrared spectroscopy imaging now allows immediate and direct visualization of tissue oxygenation which truly enhances medical decision making and will provide improved patient outcomes. The Kent team is comprised of talented and dedicated individuals working together to achieve excellence. I am thrilled to be part of this great organization."
“Dr. Niezgoda possesses a strong passion for bringing technology from the research bench to the clinical bedside where it can have a real contribution towards reducing complications and improving outcomes for patients,” says Pierre Lemire, CEO of Kent Imaging. “We are excited to have him join the Kent team to help optimize the use of SnapshotNIR in all points of care.”
Jeffrey Niezgoda is dedicated to excellence in wound, vascular, and regenerative clinical services as the founder and President Emeritus of AZH Wound & Hyperbaric Medicine. He is the President & CMO of WebCME, an international educational company providing wound care and hyperbaric education. He is the President of the American Professional Wound Care Association and Past-President of the American College of Hyperbaric Medicine. As an early adopter and supporter of Kent’s flagship product, SnapshotNIR, Dr. Niezgoda has been using the device for nearly 4 years.